| (V480) |
The ARVC-5 Newfoundland mutation (TMEM43 p.S358L) found in a German family with arrhythmogenic right ventricular cardiomyopathy (ARVC) |
|
C. Baecker, J. Müsebeck, B. Klauke, M. Paul, E. Schulze-Bahr, D. Gerdes, J. Gummert, A. Gärtner, H. Milting (Bad Oeynhausen, Bremen, Münster) |
| (V481) |
In vitro functional analysis of ARVC-related desmoglein 2 (DSG2-)-mutations |
|
A. Gärtner, B. Klauke, I. Stork, J. Gummert, H. Milting (Bad Oeynhausen) |
| (V482) |
Conversion of irregular atrial activity into regular atrial activity due to an increase of refractory period and interatrial conduction time in an isolated rabbit heart model of chronic heart failure |
|
S. Ghezelbash, G. Frommeyer, T. Uphaus, D. Kaiser, L. Eckardt, P. Milberg (Münster) |
| (V483) |
Phosphatase-1-Inhibitor-1 ablation does not rescue the heart failure phenotype in CaMKIIδc transgenic mice |
|
C. Brammen, K. Wittköpper, S. Neef, T. Sowa, T. Schulte, R. Blume, L. S. Maier, A. El-Armouche (Göttingen) |
| (V484) |
CYP2J2 overexpression protects against arrhythmias in two different models of cardiac hypertrophy |
|
R. Fischer, B. Spallek, A. Konkel, C. Westphal, L. Marko, L. M. DeGraf, C. Schubert, A. Bradbury, R. Dechend, F. C. Luft, V. Regitz-Zagrosek, D. C. Zeldin, D. Müller, W.-H. Schunck (Berlin; Research Triangle Park, US) |
| (V485) |
Acute effects of local versus global cardiac stretch on local electrical activation and repolarisation. |
|
S. Dhein, S. Riethdorf, F. W. Mohr (Leipzig) |